Asthma
📧 Sign up to get email alerts when something new happens for Asthma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-10-23Clinical Trial Update: EValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 Patients [Phase 4]
Phase 4 trial comparing dupilumab versus omalizumab in Type 2 inflammatory disease patients (chronic rhinosinusitis with nasal polyps and as…
-
CLINICAL_TRIALS trial_result · 2025-10-23Clinical Trial Update: Phase II Study to Evaluate the Effect of AZD4604 on Airway Inflammation and Biomarkers in Adults With Asthma [Phase 2]
Phase II trial evaluating AZD4604 on airway inflammation and biomarkers in adults with asthma has completed. The snippet does not provide st…
-
EMA approval · 2025-10-22EMA Authorised: Tezspire (tezepelumab) — AstraZeneca AB
The European Medicines Agency authorised Tezspire (tezepelumab) by AstraZeneca AB for the treatment of asthma and sinusitis in the EU.
-
CLINICAL_TRIALS trial_result · 2025-10-21Clinical Trial Update: Promoting Asthma Guidelines and Management Through Technology-Based Intervention and Care Coordination [NA]
This clinical trial update reports completion of a technology-based intervention and care coordination program designed to promote asthma gu…
-
CLINICAL_TRIALS trial_result · 2025-10-21Clinical Trial Update: Study in Portuguese Hospitals to Describe Patient Characteristics, Treatment Patterns and Outcomes
A completed AstraZeneca-sponsored observational study in Portuguese hospitals describes patient characteristics, treatment patterns, and out…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-10-20Clinical Trial Update: Characterization and Clinical Outcomes of Severe Asthma Patients in Israel Treated With Benralizumab (SAIL-B)
This update summarizes results from a completed clinical trial (SAIL-B) evaluating characterization and clinical outcomes of severe asthma p…
-
CLINICAL_TRIALS research · 2025-10-20Clinical Trial Update: Effect of Linvemastat in Patients With Partially Controlled Asthma (syMMPonia) [Phase 2]
Phase 2 clinical trial evaluating Linvemastat in patients with partially controlled asthma; the study is currently not yet recruiting.
-
FDA approval · 2025-10-17FDA Approved: TEZSPIRE — Supplemental Application (Amgen Inc)
FDA approved a supplemental application for TEZSPIRE (TEZEPELUMAB-EKKO) from Amgen Inc.
-
CLINICAL_TRIALS trial_result · 2025-10-15Clinical Trial Update: A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype [Phase 3]
Phase 3 study comparing depemokimab (GSK3511294) with mepolizumab or benralizumab in participants with severe eosinophilic asthma; the trial…
-
CLINICAL_TRIALS trial_result · 2025-10-14Clinical Trial Update: A Study of Inhaled AZD8630 in Adolescents With Asthma [Phase 1]
A Phase 1 study evaluating inhaled AZD8630 in adolescents with asthma has completed.
-
CLINICAL_TRIALS trial_result · 2025-10-14Clinical Trial Update: Effectiveness and Safety Study of Tezepelumab in Adults & Adolescent Participants With Severe Asthma in the United States [Phase 4]
Phase 4 study evaluating effectiveness and safety of tezepelumab in adults and adolescents with severe asthma; the trial status is COMPLETED…
-
CLINICAL_TRIALS research · 2025-10-14Clinical Trial Update: Inhaler Trainer Efficacy Study [NA]
A clinical trial update indicates recruitment for a study evaluating an inhaler trainer device for asthma and chronic obstructive pulmonary …
-
EMA approval · 2025-10-07EMA Authorised: Bemrist Breezhaler (indacaterol;mometasone furoate) — Novartis Europharm Limited
The EMA authorised Bemrist Breezhaler, a fixed-dose inhaler combining indacaterol and mometasone furoate, for asthma; the marketing authoriz…
-
CLINICAL_TRIALS research · 2025-10-07Clinical Trial Update: A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma [Phase 3]
A Phase 3 trial is evaluating the efficacy, safety and tolerability of FF/UMEC/VI versus FF/VI in adolescents aged 12-17 with asthma. The st…
-
CLINICAL_TRIALS trial_result · 2025-10-03Clinical Trial Update: A Safety, Pharmacokinetic, and Pharmacodynamic Study of Once Daily Inhaled AZD8630 in Adults With Asthma [Phase 1]
A Phase 1 study assessed the safety, pharmacokinetics, and pharmacodynamics of once-daily inhaled AZD8630 in adults with asthma; the trial i…
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: AIRWEIGHS: Investigating Obesity as a Susceptibility Factor for Air Pollution in Childhood Asthma [NA]
Johns Hopkins University is conducting the AIRWEIGHS study to examine whether obesity modifies the impact of air pollution on childhood asth…
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: AeviceMD for Detection of Wheeze in Pediatric and Adult Populations
A clinical trial update indicates that AeviceMD is currently recruiting pediatric and adult participants to detect wheeze in subjects presen…
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: Clock Proteins as Prognostic Markers
A clinical trial investigating clock proteins as prognostic markers in severe eosinophilic asthma was terminated.
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Observational Retrospective Study To Characterize and Assess Clinical Outcomes of Patients Receiving Tezepelumab in the Framework Of Use in Special Situations Prior to Commercialisation in Spain
A retrospective observational study to characterize clinical outcomes of patients treated with tezepelumab in special-use settings prior to …
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Early Identification of Children With Asthma
Trial update from University Hospital, Rouen describes a study aimed at early identification of asthma in children. The study is not yet rec…
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: Primary Care Implementation and Evaluation of Coach McLungs [NA]
Wake Forest University Health Sciences reports on a clinical trial evaluating the Coach McLungs program for asthma in primary care; the stud…
-
FDA approval · 2025-09-30FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for Montelukast Sodium by Amneal Pharmaceuticals LLC. This approval relates to an updated labeling o…
-
CLINICAL_TRIALS research · 2025-09-30Clinical Trial Update: Fish Oil in pREgnancY for Personalized Prevention of Early Childhood Asthma [Phase 3]
Phase 3 clinical trial update on using fish oil during pregnancy to personalize prevention of early childhood asthma. The study is currently…
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: Mepolizumab Pharmacokinetics Among Patients With Severe Asthma [NA]
A completed clinical trial update detailing the pharmacokinetics of mepolizumab in patients with severe asthma.
-
CLINICAL_TRIALS research · 2025-09-30Clinical Trial Update: VItamin D in pregnanCy for prevenTion Of eaRlY Childhood Asthma [Phase 3]
A Phase 3 clinical trial is investigating whether vitamin D supplementation during pregnancy can prevent asthma in early childhood and is cu…